Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Principles of Pharmacogenetics: Types of Genetic Variants

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasmid DNAs encoding insulin and glutamic acid decarboxylase 65 have distinct effects on the progression of autoimmune diabetes in nonobese diabetic mice.

Journal of immunology (Baltimore, Md. : 1950)·2001

Same author

[Study of the cytotoxity against human hepatocellular carcinoma cells induced by the MAGE-1 gene modified dendritic cells].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2001

Same author

Anodic cyclization reactions: reversing the polarity of ketene dithioacetal groups.

Organic letters·2001

Same author

Differential effects of protein kinase C on human vascular smooth muscle cell proliferation and migration.

American journal of physiology. Heart and circulatory physiology·2001

Same author

Assessment of total energy expenditure in a Chinese population by a physical activity questionnaire: examination of validity.

International journal of food sciences and nutrition·2001

Same author

Downregulation of the ERK 1 and 2 mitogen activated protein kinases using antisense oligonucleotides inhibits proliferation of porcine vascular smooth muscle cells.

Atherosclerosis·2001

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

[Study on apoE gene polymorphism in Chinese type II b hyperlipidemia].

X Zhang¹, H Bai, B Liu

¹Apolipoprotein Research Unit, WCUMS, Chengdu 610041, China.

Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao

|February 26, 2003

Summary

Apolipoprotein E (apoE) gene variations influence lipid levels in Chinese patients with type IIb hyperlipoproteinemia. Alleles epsilon 2 and epsilon 4 are linked to altered triglyceride, cholesterol, and apolipoprotein levels, impacting cardiovascular risk.

More Related Videos

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes

Published on: July 17, 2021

Related Experiment Videos

Last Updated: Jul 20, 2026

Quantification of Atherosclerosis in Mice

Quantification of Atherosclerosis in Mice

Published on: June 12, 2019

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Isolation and Analysis of Plasma Lipoproteins by Ultracentrifugation

Published on: January 28, 2021

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes

Application of DNA Fingerprinting using the D1S80 Locus in Lab Classes

Published on: July 17, 2021

Area of Science:

Genetics and Molecular Biology
Cardiovascular Research
Biochemistry

Context:

Type IIb hyperlipoproteinemia is a dyslipidemic condition characterized by elevated triglycerides and cholesterol.
Apolipoprotein E (apoE) plays a crucial role in lipoprotein metabolism.
Understanding apoE polymorphism in diverse populations is vital for personalized medicine.

Purpose:

To investigate the association between apolipoprotein E (apoE) gene polymorphism and plasma lipid and apolipoprotein levels.
To analyze apoE genotypes using polymerase chain reaction (PCR)-restriction fragment length polymorphism (RFLP).
To compare lipid and apolipoprotein profiles between 74 Chinese patients with type IIb hyperlipoproteinemia and 230 healthy controls.

Summary:

Patients with type IIb hyperlipoproteinemia exhibited significantly higher serum triglycerides (TG), total cholesterol (TC), LDL-C, non-HDL-C, and specific apolipoproteins (apoA II, apoB100, apoC II, apoC III, apoE) compared to controls.
The apoE3/3 genotype and epsilon 3 allele were most frequent in both groups. Allele epsilon 2 showed a trend towards increase, while epsilon 4 showed a trend towards decrease in patients.
Specific apoE genotypes were linked to lipid profiles: apoE2 associated with higher TG and apoC II/apoE levels; apoE4 associated with higher TC, non-HDL-C, and apoE levels.

Impact:

The study highlights the influence of apoE alleles epsilon 2 and epsilon 4 on serum lipid and apolipoprotein levels in Chinese individuals with type IIb hyperlipoproteinemia.
Findings contribute to understanding the genetic underpinnings of dyslipidemia in this population.
This knowledge may aid in risk stratification and targeted therapeutic strategies for hyperlipoproteinemia.